Is there a vaccine for the Nipah virus? Early human trials show a new vaccine is safe and triggers strong immune responses.

Invasive Anopheles stephensi mosquitoes in urban India jeopardize malaria elimination goals, highlighting urgent surveillance ...

Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive ...

Gene Holdings Inc. rises on 62% CR rate in Phase 2 NMIBC trial. Click to learn about ENGN and its gene delivery tech, market ...

In 2026, banks face converging pressure from AI, fraud, and data demands. Why hesitation is a competitive risk—and what ...

We’ve celebrated an extraordinary breakthrough while largely postponing the harder question of whether the architecture we’re scaling can sustain the use cases promised.

Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...

D Molecular Therapeutics, Inc. (NASDAQ:FDMT) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, 4D ...

Quantum computing is a promising field with massive long-term potential, but it is still in its early commercialization phase ...

From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...

Despite the sharp decline in overall funding, Delphi Digital highlights the "stealthy rise" of a hybrid model known as Web2.5 as a resilient growth vector for ...